输注浓缩红细胞储存时间与外科重症成人结局的关联:年龄血液评估随机试验的亚组分析
该研究为ABLE随机对照试验的外科非创伤成人亚组分析,纳入ICU内首周申请首次红细胞输注且预计机械通气≥48小时的外科患者320例,其中围手术期患者172例分配至新鲜组(储存≤7天)、148例分配至标准组。新鲜组实际储存时间7.2±6.4天,标准组20.6±8.4天(p<0.0001)。主要终点90天全因死亡率分别为29.7%和28.4%(绝对风险差0.01,95%CI -0.09至0.11,p=0.803),所有次要终点包括6个月死亡率均无显著差异,即便校正年龄、国家和APACHE评分后亦然。结论认为在外科重症患者中无证据表明新鲜红细胞改善结局,与ABLE试验其他患者一致。
要点
- 外科重症患者中,新鲜红细胞(储存≤7天)与标准发放红细胞相比,90天全因死亡率无显著差异:29.7% vs 28.4%(绝对风险差0.01,95%CI -0.09至0.11,p=0.803)。
- 6个月死亡率及其他所有次要终点均无显著差异,校正年龄、国家和APACHE评分后结果不变。
- 实际储存时间:新鲜组7.2±6.4天,标准组20.6±8.4天(p<0.0001)。
- 该亚组分析纳入的是ICU首周申请首次红细胞输注且预计机械通气≥48小时的外科非创伤成人,排除了择期心脏手术和创伤。
- 结论与ABLE主试验一致:无证据表明新鲜红细胞对外科重症患者更优。
适用人群与场景
- ABLE随机对照试验中纳入的外科非创伤成人,共320例,均为ICU患者,在入住ICU第一周内申请首次红细胞输注,且预计机械通气时间≥48小时。
- 纳入围手术期患者,但排除择期心脏手术和创伤患者。
处置流程与药物剂量
- 外科参与者被分配接受储存≤7天的红细胞单位(新鲜组,n=172)或标准发放红细胞(标准组,n=148)。
研究设计与关键结果
- 设计:ABLE随机对照试验的外科非创伤成人亚组分析,共纳入320例外科患者(来自ABLE研究的2510例ICU成人),其中新鲜组172例、标准组148例。
- 干预与对照:新鲜组接受储存≤7天的红细胞单位,标准组接受标准发放红细胞;实际储存时间新鲜组7.2±6.4天 vs 标准组20.6±8.4天(p<0.0001)。
- 主要终点:90天全因死亡率新鲜组29.7% vs 标准组28.4%,绝对风险差0.01(95%CI -0.09至0.11),p=0.803。
- 次要终点:所有次要终点包括6个月死亡率均无显著差异,校正年龄、国家和急性生理与慢性健康评估(APACHE)评分后仍无显著差异。
- 基线资料两组相似。
证据类型、等级与局限
- 证据类型:随机对照试验(ABLE)的亚组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在外科重症成人中,新鲜红细胞(储存≤7天)与标准发放红细胞相比未显示改善结局,与ABLE试验其他患者一致;原文未据此给出推荐。
指南或共识出处
- Age of Blood Evaluation(ABLE)随机对照试验
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The Age of Blood Evaluation (ABLE) study reported no clinical benefit in fresher compared with standard delivery RBC units (length of storage: 6.9 ± 4.1 vs 22.0 ± 8.4 d, respectively). Perioperative patients are often anemic, at risk of blood loss, and more exposed to RBC transfusions. We address the question whether fresh RBC units are safer than standard delivery RBC units in perioperative ICU patients.
DESIGN: Subgroup analysis of surgical nontrauma adults enrolled in the ABLE randomized controlled trial.
PATIENTS: Three hundred twenty surgical patients among the 2,510 ICU adults recruited in the ABLE study who had a request for a first RBC transfusion in the first week in ICU stay and an anticipated length of mechanical ventilation greater than or equal to 48 hours. We included perioperative patients but excluded elective cardiac surgery and trauma.
INTERVENTIONS: Surgical participants were allocated to receive either RBC units stored less than or equal to 7 days or standard issue RBC.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was 90-day all-cause mortality. One hundred seventy-two perioperative patients were allocated to the fresh and 148 to the standard group. Baseline data were similar. The length of storage was 7.2 ± 6.4 in fresh and 20.6 ± 8.4 days in standard group ( p < 0.0001). The 90-day mortality was 29.7% and 28.4%, respectively (absolute risk difference: 0.01; 95% CI -0.09 to 0.11; p = 0.803). No significant differences were observed for all secondary outcomes, including 6-month mortality, even after adjustment for age, country, and Acute Physiology and Chronic Health Evaluation score.
CONCLUSIONS: There was no evidence that fresh red cells improved outcomes as compared to standard issue red cells in critically ill surgical patients, consistent with other patients enrolled in the ABLE trial.
参考来源
- Lehr AR, Hébert P, Fergusson D, et al. Association Between Length of Storage of Transfused Packed RBC Units and Outcome of Surgical Critically Ill Adults: A Subgroup Analysis of the Age of Blood Evaluation Randomized Trial. Crit Care Med. 2022. PMID: 36728823. doi:10.1097/CCM.0000000000005775
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。